2-((4-chlorobenzyl)amino)-2-oxoacetic acid | 6951-40-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-((4-chlorobenzyl)amino)-2-oxoacetic acid
• 英文别名: 2-[(4-chlorophenyl)methylamino]-2-oxoacetic acid
• CAS: 6951-40-2
• 化学式: C₉H₈ClNO₃
• 分子量: 213.62
• InChiKey: IJNINFHSLXNDSM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  66.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-((4-chlorobenzyl)amino)-2-oxoacetic acid 在 N-甲基咪唑 、 盐酸 、 N,N,N',N'-tetramethylchloroformamidinium hexafluorophosphate 作用下， 以 1,4-二氧六环 、 二氯甲烷 为溶剂， 反应 7.0h， 生成 methyl 5-(azetidin-3-yloxy)-2-(2-((4-chlorobenzyl)amino)-2-oxoacetamido)-benzoate
  参考文献：
  名称：

  [EN] INHIBITORS OF MSBA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
  [FR] INHIBITEURS DE MSBA EN TANT QU'ANTIBIOTIQUES, COMPOSITIONS PHARMACEUTIQUES ET LEURS UTILISATIONS

  摘要：

  The present disclosure is directed to certain functionalized dual substituted arene derivatives (e.g., arenesulfonamide, arenesulfamide, areneoxalamide and areneamide derivatives) of Formula I: and pharmaceutically acceptable salts thereof, wherein X1, X2, Y, Z, G, R1, R2, R3, R4, and R5are as defined herein, which are potent inhibitors of MsbA and may be useful in the treatment of infections caused by any multi-drug resistant (MDR) Gram-negative bacteria. The disclosure is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of infections in which MsbA is involved.

  公开号：

  WO2023224893A1
• 作为产物：
  描述：

  N-Ethoxyoxalyl-4-chlor-benzylamin 在 lithium hydroxide 作用下， 以 四氢呋喃 、 水 为溶剂， 生成 2-((4-chlorobenzyl)amino)-2-oxoacetic acid
  参考文献：
  名称：

  可见光介导的氨基甲酰基向杂芳烃的加成†

  摘要：

  氨基甲酰基自由基的产生，然后将它们加到杂芳烃中，是在温和的条件下通过无金属的草酸的光催化脱羧反应进行的。该方法已被用于使用α-氨基酸衍生的草酰胺酸对杂芳族碱进行氨基甲酰基化，从而得到相应的酰胺而没有外消旋化作用。

  DOI：

  10.1039/c8cc08326f

文献信息

• Urethanes synthesis from oxamic acids under electrochemical conditions
  作者：Ikechukwu Martin Ogbu、Jonathan Lusseau、Gülbin Kurtay、Frédéric Robert、Yannick Landais

  DOI：10.1039/d0cc05069e

  日期：——

  Urethane synthesis via oxidative decarboxylation of oxamic acids under mild electrochemical conditions is reported. This simple phosgene-free route to urethanes involves an in situ generation of isocyanates by anodic oxidation of oxamic acids in an alcoholic medium. The reaction is applicable to a wide range of oxamic acids, including chiral ones, and alcohols furnishing the desired urethanes in a

  报道了在温和的电化学条件下通过草酸的氧化脱羧合成氨基甲酸酯。这种简单的无光气的氨基甲酸酯途径涉及在酒精介质中通过草酸的阳极氧化原位生成异氰酸酯。该反应适用于广泛的草酰胺酸，包括手性酸，以及在不使用化学氧化剂的情况下，通过一锅法即可提供所需氨基甲酸酯的醇。
• Visible-light photocatalyzed oxidative decarboxylation of oxamic acids: a green route to urethanes and ureas
  作者：Govind Goroba Pawar、Frédéric Robert、Etienne Grau、Henri Cramail、Yannick Landais

  DOI：10.1039/c8cc05462b

  日期：——

  based on a photocatalyzed oxidative decarboxylation of oxamic acids is described. The reaction includes in situ generation of an isocyanate from the oxamic acid, using an organic dye as a photocatalyst, a hypervalent iodine reagent as an oxidant and a light source, which trigger the free-radical decarboxylation. This protocol successfully avoids the isolation, purification and storage of carcinogenic

  描述了基于光催化的肟酸的氧化脱羧，可持续的无金属途径生产氨基甲酸酯和尿素的方法。该反应包括使用有机染料作为光催化剂，高价碘试剂作为氧化剂和光源从草酰胺酸原位生成异氰酸酯，从而触发自由基脱羧。该方案成功地避免了致癌的异氰酸酯的分离，纯化和储存，并允许通过一锅法从可商购的来源精制氨基甲酸乙酯和尿素。
• Photocatalyzed decarboxylation of oxamic acids under near-infrared conditions
  作者：Ikechukwu Martin Ogbu、Dario M. Bassani、Frédéric Robert、Yannick Landais

  DOI：10.1039/d2cc03155h

  日期：——

  Photocatalyzed oxidative decarboxylation of oxamic acids under near-infrared irradiation using Os(bptpy)2(PF6)2 as catalyst is reported. The reaction was applied to the synthesis of urethanes and heterocyclic amides. Mechanistic studies and comparative penetration depths between the NIR and the visible light mediated processes are discussed.

  报道了使用Os(bptpy) 2 (PF 6 ) 2作为催化剂在近红外照射下草酸的光催化氧化脱羧。该反应用于合成氨基甲酸酯和杂环酰胺。讨论了近红外和可见光介导过程之间的机理研究和比较穿透深度。
• OXALAMIDES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
  申请人：PHENEX DISCOVERY VERWALTUNGS-GMBH

  公开号：US20200352931A1

  公开（公告）日：2020-11-12

  The present invention relates to novel compounds which act as modulators of indoleamine 2,3-dioxygenase (IDO1) and to the use of said compounds in the prophylaxis and/or treatment of diseases or conditions mediated by indoleamine 2,3-dioxygenase. The invention further relates to pharmaceutical compositions comprising the novel compounds.
• WO2023/224892
  申请人：——

  公开号：——

  公开（公告）日：——